A simple, noninvasively determined index predicting hepatic failure following liver resection for hepatocellular carcinoma

Journal of Hepato-Biliary-Pancreatic Surgery

Volumn 16, Issue 1, 2009, Pages 42-48

  Ichikawa, Tsuyoshi ^a   Uenishi, Takahiro ^b   Takemura, Shigekazu ^a   Oba, Kazuki ^a   Ogawa, Masao ^a   Kodai, Shintaro ^a   Shinkawa, Hiroji ^a   Tanaka, Hiromu ^a   Yamamoto, Takatsugu ^b   Tanaka, Shogo ^a   Yamamoto, Satoshi ^a   Hai, Seikan ^a   Shuto, Taichi ^c   Hirohashi, Kazuhiro ^c   Kubo, Shoji ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Ishikiriseiki Hospital   (Japan)

^c OSAKA CITY UNIVERSITY HOSPITAL   (Japan)

Author keywords

APRI; Hepatocellular carcinoma; Liver failure; Liver resection; Platelet count

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; ASCITES; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; HEPATIC COMA; HEPATITIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERBILIRUBINEMIA; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER FIBROSIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INVASIVE PROCEDURE; OUTCOME ASSESSMENT; PLEURA EFFUSION; PREDICTION; PREOPERATIVE EVALUATION; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; THROMBOCYTE COUNT;

ADULT; AGED; AGED, 80 AND OVER; ASPARTATE AMINOTRANSFERASES; BIOLOGICAL MARKERS; CARCINOMA, HEPATOCELLULAR; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; LIVER FAILURE; LIVER NEOPLASMS; LOGISTIC MODELS; MALE; MIDDLE AGED; PLATELET COUNT; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; RISK FACTORS; STATISTICS, NONPARAMETRIC;

EID: 59849095267     PISSN: 09441166     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00534-008-0003-4     Document Type: Article

References (43)

1. Lai EC, Fan ST, Lo CM, Chu KM, Liu CL, Wong J. Hepatic resection for hepatocellular carcinoma. An audit of 343 patients. Ann Surg. 1995;221:291-8.
2. Takenaka K, Kawahara N, Yamamoto K, Kajiyama K, Maeda T, Itasaka H, et al. Results of 280 liver resections for hepatocellular carcinoma. Arch Surg. 1996;131:71-6.
3. Wu CC, Ho WL, Yeh DC, Huang CR, Liu TJ, P'Eng FK. Hepatic resection of hepatocellular carcinoma in cirrhotic livers: Is it unjustified in impaired liver function? Surgery. 1996;120:34-9.
4. Cohnert TU, Rau HG, Buttler E, Hernandez-Richter T, Sauter G, Reuter C, et al. Preoperative risk assessment of hepatic resection for malignant disease. World J Surg. 1997;21:396-400.
5. Lau H, Man K, Fan ST, Yu WC, Lo CM, Wong J. Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy. Br J Surg. 1997;84:1255-9.
6. Lise M, Bacchetti S, Da Pian P, Nitti D, Pilati PL, Pigato P. Prognostic factors affecting long term outcome after liver resection for hepatocellular carcinoma: Results in a series of 100 Italian patients. Cancer. 1998;82:1028-36.
7. Nonami T, Nakao A, Kurokawa T, Inagaki H, Matsushita Y, Sakamoto J, et al. Blood loss and ICG clearance as best prognostic markers of post-hepatectomy liver failure. Hepatogastroenterology. 1999;46:1669-72.
8. Pol B, Campan P, Hardwigsen J, Botti G, Pons J, Le Treut YP. Morbidity of major hepatic resections: A 100-case prospective study. Eur J Surg. 1999;165:446-53.
9. Farges O, Malassagne B, Flejou JF, Balzan S, Sauvanet A, Belghiti J. Risk of major liver resection in patients with underlying chronic liver disease: A reappraisal. Ann Surg. 1999;229:210-5.
10. Yamanaka N, Okamoto E, Kuwata K, Tanaka N. A multiple regression equation for prediction of posthepatectomy liver failure. Ann Surg. 1984;200:658-63.
11. Didolkar MS, Fitzpatrick JL, Elias EG, Whitley N, Keramati B, Suter CM, et al. Risk factors before hepatectomy, hepatic function after hepatectomy and computed tomographic changes as indicators of mortality from hepatic failure. Surg Gynecol Obstet. 1989;169:17-26.
12. Noguchi T, Imai T, Mizumoto R. Preoperative estimation of surgical risk of hepatectomy in cirrhotic patients. Hepatogastroenterology. 1990;37:165-71.
13. Shimada M, Matsumata T, Akazawa K, Kamakura T, Itasaka H, Sugimachi K, et al. Estimation of risk of major complications after hepatic resection. Am J Surg. 1994;167:399-403.
14. Kwon AH, Ha-Kawa SK, Uetsuji S, Kamiyama Y, Tanaka Y. Use of technetium 99 m diethylenetriamine-pentaacetic acid-galactosyl-human serum albumin liver scintigraphy in the evaluation of preoperative and postoperative hepatic functional reserve for hepatectomy. Surgery. 1995;117:429-34.
15. Bruix J, Castells A, Bosch J, Feu F, Fuster J, Garcia-Pagan JC, et al. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology. 1996;111:1018-22.
16. Zimmermann H, Reichen J. Hepatectomy: Preoperative analysis of hepatic function and postoperative liver failure. Dig Surg. 1998;15:1-11.
17. Kubota K, Makuuchi M, Kusaka K, Kobayashi T, Miki K, Hasegawa K, et al. Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology. 1997;26:1176-81.
18. Miyagawa S, Makuuchi M, Kawasaki S, Kakazu T. Criteria for safe hepatic resection. Am J Surg. 1995;169:589-94.
19. Belghiti J, Ogata S. Assessment of hepatic reserve for indication of hepatic resection. J Hepatobiliary Pancreat Surg. 2005;12:1-3.
20. Nagasue N, Yukaya H, Ogawa Y, Kohno H, Nakamura T. Human liver regeneration after major hepatic resection. A study of normal liver and livers with chronic hepatitis and cirrhosis. Ann Surg. 1987;206:30-9.
21. Das BC, Isaji S, Kawarada Y. Analysis of 100 consecutive hepatectomies: risk factors in patients with liver cirrhosis or obstructive jaundice. World J Surg. 2001;25:266-72. discussion 272-273.
22. Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003;38:518-26.
23. Castera L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, Haaser M, et al. Prospective comparison of transient elastography, fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology. 2005;128:343-50.
24. Horii K, Kubo S, Hirohashi K, Kinoshita H. Changes in erythrocyte deformability after liver resection for hepatocellular carcinoma associated with chronic liver disease. World J Surg. 1999;23:85-90.
25. Kubo S, Tsukamoto T, Hirohashi K, Tanaka H, Shuto T, Takemura S, et al. Correlation between preoperative serum concentration of type IV collagen 7 s domain and hepatic failure following resection of hepatocellular carcinoma. Ann Surg. 2004;239:186-93.
26. Liver Cancer Study Group of Japan. Classification of primary liver cancer. 1st English ed. Tokyo: Kanehara; 1997.
27. Edmondson HA, Steiner PE. Primary carcinoma of the liver: A study of 100 cases among 48, 900 necropsies. Cancer. 1954;7:462-503.
28. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology. 1981;1:431-5.
29. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: Diagnosis, grading and staging. Hepatology. 1994;19:1513-20.
30. Liver Cancer Study Group of Japan. Primary liver cancer in Japan: clinicopathological features and results of surgical treatment. Ann Surg. 1990;211:277-87.
31. Nagasue N, Kohno H, Tachibana M, Yamanoi A, Ohmori H, El-Assal ON. Prognostic factors after hepatic resection for hepatocellular carcinoma associated with child-Turcotte class B and C cirrhosis. Ann Surg. 1999;229:84-90.
32. Takenaka K, Kanematsu T, Fukuzawa K, Sugimachi K. Can hepatic failure after surgery for hepatocellular carcinoma in cirrhotic patients be prevented? World J Surg. 1990;14:123-7.
33. Miyazaki S, Takasaki K, Yamamoto M, Tsugita M, Otsubo T. Liver regeneration and restoration of liver function after partial hepatectomy: The relation of fibrosis of the liver parenchyma. Hepatogastroenterology. 1999;46:2919-24.
34. Tanaka S, Kubo S, Tsukamoto T, Hirohashi K, Tanaka H, Shuto T, et al. Risk factors for intractable pleural effusion after liver resection. Osaka City Med J. 2004;50:9-18.
35. Eguchi H, Umeshita K, Sakon M, Nagano H, Ito Y, Kishimoto SI, et al. Presence of active hepatitis associated with liver cirrhosis is a risk factor for mortality caused by posthepatectomy liver failure. Dig Dis Sci. 2000;45:1383-8.
36. Fan ST, Lai EC, Lo CM, Ng IO, Wong J. Hospital mortality of major hepatectomy for hepatocellular carcinoma associated with cirrhosis. Arch Surg. 1995;130:198-203.
37. Matsumata T, Kanematsu T, Yoshida Y, Furuta T, Yanaga K, Sugimachi K. The indocyanine green test enables prediction of postoperative complications after hepatic resection. World J Surg. 1987;11:678-81.
38. Fujio N, Sakai K, Kinoshita H, Hirohashi K, Kubo S, Iwasa R, et al. Results of treatment of patients with hepatocellular carcinoma with severe cirrhosis of the liver. World J Surg. 1989;13:211-7. discussion 217-218.
39. Hemming AW, Scudamore CH, Shackleton CR, Pudek M, Erb SR. Indocyanine green clearance as a predictor of successful hepatic resection in cirrhotic patients. Am J Surg. 1992;163:515-8.
40. Yasui M, Harada A, Torii A, Nakao A, Nonami T, Takagi H. Impaired liver function and long-term prognosis after hepatectomy for hepatocellular carcinoma. World J Surg. 1995;19:439-43.
41. Midorikawa Y, Kubota K, Takayama T, Toyoda H, Ijichi M, Torzilli G, et al. A comparative study of postoperative complications after hepatectomy in patients with and without chronic liver disease. Surgery. 1999;126:484-91.
42. Imamura H, Sano K, Sugawara Y, Kokudo N, Makuuchi M. Assessment of hepatic reserve for indication of hepatic resection: Decision tree incorporating indocyanine green test. J Hepatobiliary Pancreat Surg. 2005;12:16-22.
43. Poon RT, Fan ST, Tsang FH, Wong J. Locoregional therapies for hepatocellular carcinoma: A critical review from the surgeon's perspective. Ann Surg. 2002;235:466-86.